HapA protease targets PAR-1/2 to modulate ERK signalling and reduce cancer cell viability
- DOI
- 10.5167/uzh-280758
- Published
- 2025
- Container
- Not recorded
- Publisher
- Nature Publishing Group
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.5167/uzh-280758,
title = {HapA protease targets PAR-1/2 to modulate ERK signalling and reduce cancer cell viability},
author = {Tena-Chaves, David and Pontes-Gomes, Inês and Palomeque, José Ángel and Toh, Eric and Baryalai, Palwasha and Kadler, Gabor and Schüpbach, Reto and Heuberger, Dorothea M and Hurtado, Antoni and Wai, Sun Nyunt},
year = {2025},
doi = {10.5167/uzh-280758},
url = {https://doi.org/10.5167/uzh-280758}
}RIS
TY - JOUR TI - HapA protease targets PAR-1/2 to modulate ERK signalling and reduce cancer cell viability AU - Tena-Chaves, David AU - Pontes-Gomes, Inês AU - Palomeque, José Ángel AU - Toh, Eric AU - Baryalai, Palwasha AU - Kadler, Gabor AU - Schüpbach, Reto AU - Heuberger, Dorothea M AU - Hurtado, Antoni AU - Wai, Sun Nyunt PY - 2025 DO - 10.5167/uzh-280758 UR - https://doi.org/10.5167/uzh-280758 ER -
APA
David, T., Inês, P., Ángel, P. J., Eric, T., Palwasha, B., Gabor, K., Reto, S., M, H. D., Antoni, H., & Nyunt, W. S. (2025). HapA protease targets PAR-1/2 to modulate ERK signalling and reduce cancer cell viability. https://doi.org/10.5167/uzh-280758
Source records
- datacite · retrieved 2026-09-26T13:25:30.140Z